Skip to main content
. 2019 Sep 23;8(12):e1665973. doi: 10.1080/2162402X.2019.1665973

Figure 2.

Figure 2.

The associations between antibiotic use and overall survival (a) and progression-free survival (b) in cancer patients treated with immune checkpoint inhibitors.